logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

5 Micro and Small-Cap Biotechs Developing Stem Cell Treatments

By  +Follow August 1, 2013 8:43AM
Share:
Tickers Mentioned:

Stem cells have once again flitted through the news cycle, this time as a result of a new and growing industry that has arisen around the use of adult stem cells in cosmetic treatments that purport to both be more effective and less dangerous than traditional procedures such as the infamous and potentially toxic Botox injections.

But the scientific basis for the use of stem cells for cosmetic procedures is entirely tentative. To date, the US Food and Drug Administration has not approved any stem cell-based products for use, aside from a small number of umbilical cord blood-derived treatments for blood cancer as well as hereditary metabolic and autoimmune disorders.

Cosmetic treatments of any variety are subject to far less scrutiny than medical treatments, however, and this is what is currently allowing an increasing amount of doctors throughout the country to charge as much as $30,000 for procedures whose value are more or less unproven from the standpoint of official studies, clinical trials, and peer reviews.

Considering that so few medical products involving stem cells have been approved, a high degree of skepticism should probably be applied to any magical claims about the potential for stem cells to make one look younger, or to otherwise repair one’s perceived cosmetic iniquities. A terrifying article that appeared last December in The Scientific American suffices to support this contention.

But stem cells, whether of the adult of cord-blood variety, are believed to have regenerative properties that could repair all manner of human diseases and conditions, from cardiovascular conditions, to autoimmune diseases. The following five companies are biotechs that are working to ostensibly better the human condition through the use of stem-cell technology, and are all in the midst of clinical trials for various treatments, or on their way to beginning them

Osiris Therapeutics (OSIR) — With a market cap of $377 million, the Columbia, Maryland-based Osiris Therapeutics focuses on the development and marketing of stem cell products to treat serious inflammatory, autoimmune, orthopedic, and cardiovascular conditions. The company’s shares are currently priced at $11.45 and are up over 38 percent over the last six months.

Pluristem (PSTI) — The Israel-based Pluristem develops stem cell therapies from placenta cells for a number of diseases, and is currently preparing for clinical trials for a Peripheral Artery Disease treatment. The company has a market cap of $173.9 million, with shares trading at $2.98, down 7 percent over the past half year.

Cytori Therapeutics (CYTX) — Cytoris Therapeutics uses adult stem cells to develop regenerative therapies for cardiovascular conditions and soft tissue defects. The US company has a market cap of $188.9 million with shares currently priced at $2.82, up 2.5 percent over the last six months.

Neostem (NBS) — The New York, NY-based Neostem owns and operates a number of subsidiaries in the stem-cell based regenerative medicine industry that develop treatments for cardiovascular, autoimmune, and inflammatory conditions. The company is nearing clinical trials for a periodontitis treatment. With a market cap of $117.7 million, shares are currently priced at $7.05, up 10 percent over the past six months, and 17 percent year-to-date.

Advanced Cell Technology ($ACTC) — The Santa Monica, CA-based Advanced Cell Technology uses both adult and embryonic stem cells to develop treatments for retinal, blood, and heart diseases, and has recently initiated two different clinical trials for degenerative retinal disease. With a market cap of $179 million, shares are currently priced at $0.07, down $0.01 over the past six months.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for cytx
RoyHarris
25 Oct 14 01:35:13
RT @TECHNICALGUY111: 10/27📈20Reversals $HEAR $EXEL $OPWR $MINE $KTOS $FREE $WPCS $STEM $BIOL $XGTI $SGLB $CYTX $YOD $ARTX $RGSE $PAL $GTATQ…
*Watchlist&Rationale
25 Oct 14 01:34:36
10/27📈20Reversals $HEAR $EXEL $OPWR $MINE $KTOS $FREE $WPCS $STEM $BIOL $XGTI $SGLB $CYTX $YOD $ARTX $RGSE $PAL $GTATQ $KNDI $CSLT $WAVX 💰
*Watchlist&Rationale
24 Oct 14 21:52:46
10/27 wkly list cont>>> $NIHDQ $GTATQ $RGSE $BORN $BIOL $DSS $CSLT $WAVX $KNDI $ARTX $BLDP $CYTX $DARA $DRYS $ISR $ZIOP $OMEX $EXEL $ACUR
Stock Moo
24 Oct 14 17:37:04
$cytx: Cytori to Webcast Third Quarter Financial Results on November 6 http://t.co/RFzeVLnADC
Stock Moo
24 Oct 14 16:36:46
$cytx: Cytori to Webcast Third Quarter Financial Results on November 6 http://t.co/FJ61hUQ892
Pzaa...Guy
24 Oct 14 16:07:11
$CYTX - Cytori to Webcast Third Quarter Financial Results on November 6 http://t.co/6Kavpu6zXB
StockNews
24 Oct 14 16:07:07
$CYTX - Cytori to Webcast Third Quarter Financial Results on November 6 http://t.co/vC91odqfVN
Stocks News&Markets
24 Oct 14 16:07:06
$CYTX - Cytori to Webcast Third Quarter Financial Results on November 6 http://t.co/5b25CKndZe
NASDAQ
24 Oct 14 16:07:02
$CYTX - Cytori to Webcast Third Quarter Financial Results on November 6 http://t.co/WN1R3QP6dK
$Stocknewsalerts
24 Oct 14 16:05:24
$CYTX Cytori - Cytori to Webcast Third Quarter Financial Results on November 6 From our Stock News Alerts App
BV Healthcare
24 Oct 14 16:05:05
$CYTX Cytori to Webcast Third Quarter Financial Results on November 6.. http://t.co/M7K5FX92zd
A P
24 Oct 14 13:27:20
$CYTX Nasdaq stocks posting largest volume increases http://t.co/EtysKGLYIJ #BiotechTraderHandbook--> http://t.co/JDdc1OTfZF
Day Trade Alerts
24 Oct 14 13:03:08
#GazerAlerts Alert results: $APT +9% $CYTX +4% $IBIO +5% $LAYN +21% $NLNK +2% $VSR +2% | via http://t.co/LQqutQYQ2N
Stock Horizon LLC
24 Oct 14 13:00:08
Alert results: http://t.co/QSYaL9Ggu3 $APT +9% $CYTX +4% $IBIO +5% $LAYN +21% $NLNK +2% $VSR +2%
Brian K Hall
24 Oct 14 12:41:09
Why Making Dramatic Moves? – Cytori Therapeutics Inc $CYTX, Forest Oil Corporation $FST, EXCO Resources Inc $XCO, http://t.co/Is9IzN2nYB
Day Trade Alerts
24 Oct 14 12:01:40
#GazerAlerts Alert updates: $APT +6% $CYTX +4% $IBIO +5% $LAYN +21% | via http://t.co/LQqutQYQ2N
Stock Horizon LLC
24 Oct 14 12:00:04
Alert updates: $APT +6% $CYTX +4% $IBIO +5% $LAYN +21% http://t.co/FgFxZXP2ok
Ernie
24 Oct 14 11:48:04
@boatman07 @Brianwihub will $CYTX rebound now?
Brian Welsh
24 Oct 14 11:28:46
RT @boatman07: @Brianwihub $CYTX the buyers of offering could sell at .52 and .57 38 million how convenient it popped when it did a week la…
Gilly
24 Oct 14 11:28:18
@Brianwihub $CYTX the buyers of offering could sell at .52 and .57 38 million how convenient it popped when it did a week later!
Brian Welsh
24 Oct 14 11:24:50
We were always thought to never compare stocks. It's kind of hard since $VTAE traded just like $CYTX yesterday.
Richard Bailey
24 Oct 14 10:46:41
RT @AlertTrade: #GazerAlerts $CYTX triggered SHORT, hit 1st predicted move @ $0.49. Alerted 09:34 @ $0.54. | via http://t.co/LQqutQYQ2N
Day Trade Alerts
24 Oct 14 10:30:11
#GazerAlerts $CYTX triggered SHORT, hit 1st predicted move @ $0.49. Alerted 09:34 @ $0.54. | via http://t.co/LQqutQYQ2N
Stock Horizon LLC
24 Oct 14 10:28:07
$CYTX triggered SHORT, hit 1st predicted move @ $0.49. Alerted 09:34 @ $0.54. http://t.co/1XkdRMoQpk
Brian Welsh
24 Oct 14 10:17:36
$VTAE exact same pattern as $CYTX yesterday. Huge gap everyone all excited then FAAAAAAAAADE!
Gilly
24 Oct 14 10:15:04
$CYTX what a bust that was. imho
Daily Contracts
24 Oct 14 08:52:00
Real-Time feed of company contracts, original agreements and executive updates from Cytori Therapeutics Inc $CYTX http://t.co/gqwpW5tHRQ
stockblaster14
24 Oct 14 07:08:40
Cytori Therapeutics Inc (CYTX) 0.51 $CYTX Nasdaq stocks posting largest volume increases AP - Thu Oct 23, 5:03 http://t.co/G3qb7SpVti
Charlie
24 Oct 14 07:06:04
$CYTX out
The Flash
24 Oct 14 06:29:56
$CYTX up a little PM Roth Capital has $3.50 PT
Captain Sequence
24 Oct 14 05:47:33
RT @ChartReaderE: $CYTX #CHART.my_theory_? http://t.co/hx1NZULG2X https://t.co/ng5NMd8R8R http://t.co/DBWb2gplFL
Captain Sequence
24 Oct 14 05:46:42
RT @Flashtrading: $CYTX Roth Capital maintains BUY rating PT $3.50. Complete notes here: http://t.co/dLHpCSPlMu
frank muller
24 Oct 14 05:00:06
RT @Investor666: $CYTX-Cytori Therapeutics Receives FDA Approval to Resume ATHENA Trial Enrollment - Yahoo Finance http://t.co/MrofcyHYII
tradeyourkidsclothes
24 Oct 14 04:57:19
RT @Investor666: $CYTX-Cytori Therapeutics Receives FDA Approval to Resume ATHENA Trial Enrollment - Yahoo Finance http://t.co/MrofcyHYII
don
24 Oct 14 03:35:58
RT @Flashtrading: $CYTX Roth Capital maintains BUY rating PT $3.50. Complete notes here: http://t.co/dLHpCSPlMu
The Flash
24 Oct 14 03:34:12
$CYTX Roth Capital maintains BUY rating PT $3.50. Complete notes here: http://t.co/dLHpCSPlMu
DailyStockPicks
23 Oct 14 22:15:46
During this #Ebola outbreak, $CYTX investors will also want to buy $SMED. They handle medical and hazardous waste http://t.co/vTV3wPBONo
equities.com
23 Oct 14 20:18:55
Cytori Therapeutics Inc (CYTX) Jumps 15.36% on October 23 $cytx http://t.co/l2KBHX6Bbv
ChartReaderE
23 Oct 14 18:12:27
$CYTX #CHART.my_theory_? http://t.co/hx1NZULG2X https://t.co/ng5NMd8R8R http://t.co/DBWb2gplFL
Quantheta
23 Oct 14 17:00:04
#VOLUMESHIFTUP $JAKK $RUBI $LOGI $GLOW $CAT $SLAB $UA $CYTX $INFN $BBW #quantheta
Stephen s
23 Oct 14 16:55:03
RT @TraderNewsDaily: Sweet sign-up bonuses on stock trading websites here http://t.co/t7bWQg3zr4 Related: $MYEC $SIRI $COCO $RAD $CYTX $FI…
ChartReaderE
23 Oct 14 16:52:09
I'm now long 3k shares $CYTX after 2k shares add @ .54
Donna Young
23 Oct 14 16:49:06
Cytori soars after FDA permits ATHENA to move forward http://t.co/I9nN6eFdZA $CYTX #pharma #FDA #biotech #biopharma
Ernie
23 Oct 14 16:41:38
@jimcramer what's the good word on $cytx? Worth a buy?
Trader News Daily
23 Oct 14 16:05:50
Sweet sign-up bonuses on stock trading websites here http://t.co/t7bWQg3zr4 Related: $MYEC $SIRI $COCO $RAD $CYTX $FITX $OIBR $APT $DVAX
12Stocks.com
23 Oct 14 16:04:53
Smallcap #Stocks Performance $INFN $KIOR $NPTN $FST $MTRN $SHLM $DAN $COCO $SCSS $CYTX $EGHT $GPI $ALIM more@ http://t.co/Giravo3fg9
super call
23 Oct 14 16:04:37
@super_calls told you baggies there was a secondary and whoever bought after hours yesterday with some twitter pumpers feel bad $CYTX
The Flash
23 Oct 14 16:01:28
$CYTX Roth Capital updated PT $3.50 http://t.co/PfVlFXLUlf
Quantheta
23 Oct 14 16:00:03
#VOLUMESHIFTUP $JAKK $BRP $INFN $CPXX $UTEK $VRSN $CYTX $CAB $BBW $GLOW #quantheta
Fahd El
23 Oct 14 14:37:20
$CYTX bought for the b/o but failed also could be a gapper but don’t like to hold o/n http://t.co/4gWts9zwVQ
				
				
By  +Follow August 1, 2013 8:43AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.